Immunotherapy Drugs Market Future Prospects and Forecast To 2030
The report " Immunotherapy Drugs Market by Drugs (Vaccines (Preventive Vaccines, Therapeutic Vaccines), Monoclonal Antibodies, Interferons Alpha & Beta, Checkpoint Inhibitors, Interleukins, and Others), by Therapy Area (Autoimmune & Inflammatory Diseases, Cancer, Infectious Diseases, and Others), by End User (Hospitals/Clinics, Cancer Research Centre, and Others), - Global Forecasts to 2030" The global Immunotherapy Drugs Market is projected to reach USD 216.1 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 12.4% during the forecast period 2024-2030. The growth of the market is majorly driven by the Rising Adoption of Targeted Therapy over Traditional Therapy Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=30071 Competitive Dashboard: The prominent key players operating in the global Immunotherapy Drugs Market Pfizer Inc AstraZeneca Johnson & Johnson Novartis International A...